Alpha-Arbutin
4-Hydroxyphenyl-alpha-D-glucopyranoside
Alpha-Arbutin 列于附件 III,只能在本记录所示条件下使用。 本记录中的最大浓度:(a) 2 % (b) 0,5 %。
如何阅读本条目
Alpha-arbutin was restricted in 2024 to 2% in face cream and 0.5% in body lotion, and carries a condition about a different substance: hydroquinone must stay at unavoidable trace level.
- Face cream: 2%. Body lotion: 0.5%.
- Hydroquinone in the formulation must be no higher than the unavoidable trace level.
- 1 February 2025 stops non-compliant products being placed on the market; 1 November 2025 stops them being made available.
- Beta-arbutin is a separate entry with its own limit — the two are not interchangeable.
The hydroquinone condition is the substantive part of this entry. Arbutin is a glycoside of hydroquinone and can release it, and hydroquinone is prohibited for skin use in the EU. The SCCS assessment that led to Regulation (EU) 2024/996 set the arbutin limits at concentrations where that release stays within what Article 17 tolerates, and the entry states the requirement directly: hydroquinone levels shall remain as low as possible and no higher than the unavoidable trace level.
For a formulator this is a specification and stability question rather than a dosing one. Free hydroquinone content depends on the raw material's purity and on what happens to the product over its life — pH, temperature and time all matter — so meeting the arbutin percentage is necessary and not sufficient.
The product types are named narrowly: face cream at 2%, body lotion at 0.5%. A serum or an essence is not a face cream, and a product outside both named types has no entry to rely on. The two 2025 dates close the transition from either end of the supply chain in the usual way.
核对依据
记录详情
最大浓度
(a) 2 % (b) 0,5 %
产品类型
其他限制
Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level.
From 1 February 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
INCI 词汇表名称
Alpha-Arbutin
化学名称
4-Hydroxyphenyl-alpha-D-glucopyranoside
监管信息
SCCS 意见
已识别的成分
关键数据
化学身份与性质

- IUPAC 名称
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol
- 分子式
- C12H16O7
- 分子量
- 272.25 g/mol
- 精确质量
- 272.08960285 Da
- XLogP3
- -0.7
- 拓扑极性表面积
- 120.0 Ų
- 氢键供体
- 5
- 氢键受体
- 7
- 共价单元
- 1
- 已定义的立体中心
- 5
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:29710
- ChEMBL:CHEMBL226495
- EPA DTXSID:DTXSID20233358
- PubMed:21529910
- PubMed:18473917
- PubMed:17442288
- PubMed:15973488
- PubMed:12843585
- PubMed:11438283
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
Alpha-Arbutin 的清单链接
Alpha-Arbutin 的相关记录
该记录的直接匹配结果有限,因此同时显示附件 III 中的相邻条目。
Retinol; Retinyl Acetate; Retinyl Palmitate
Pinene
附件 III 对 Alpha-Arbutin 意味着什么
Alpha-Arbutin 是欧盟化妆品法规 1223/2009 附件 III 中的限用物质。其在化妆品中的使用仅限于上方条目所列的特定条件,包括适用的浓度限值、产品类型限制和必须标示的警示语。
在配方中使用该物质时,必须同时满足所有条件——最大浓度、产品范围和警示标签。满足其中一项条件并不能免除其他条件。
本记录与 1 个 CosIng 清单成分相关联,便于名称和标识符的交叉引用。 本页还显示 10 条相关附件记录,其标识符、附件逻辑或命名模式存在重叠。
合规核查清单
- 确保配方浓度不超过:(a) 2 % (b) 0,5 %
- 确认产品类型相符:(a) Face cream (b) Body lotion
- 将使用条件记录在产品信息档案 (PIF) 中。